ArticleInnovation (Cambridge (Mass.))2025
aplot: Simplifying the creation of complex graphs to visualize associations across diverse data types.
Article in Innovation (Cambridge (Mass.)), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- The rate of identical-by-descent segment sharing between close and distant relatives.HGG advances · 2026Article
- Experimental and computational approaches for deep metabolome annotation with application to the ecotoxicological model organism Daphnia magna.GigaScience · 2026Article
- Machine learning-based identification of an oxidative phosphorylation signature for prognosis, immune infiltration, and drug sensitivity in ovarian cancer.Frontiers in immunology · 2026Article
- Revisiting successful aging through a machine learning approach to quantifying the influence of chronic diseases.Scientific reports · 2025Article
- ggalign: Bridging the Grammar of Graphics and Biological Multilayered Complexity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Salicylic acid and ROS signaling modulate hypocotyl elongation in darkness via NPR1 and EX1.Science advances · 2025Article
- ALCAM-CD6 axis suppression: a key determinant of immune-mediated metastasis recurrence in stage III non-small cell lung cancer.Journal for immunotherapy of cancer · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effective data visualization is crucial for researchers, revealing patterns, trends, and insights that might otherwise remain hidden. Integrating related visualizations can reveal correlations and relationships that are not evident when analyzing datasets separately. Despite increasing demand, there is a shortage of general tools to seamlessly combine diverse datasets to create complex visual representations. The
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.